Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2013
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Bladder cancer
- Focus Therapeutic Use
- 04 Jun 2013 Updated results for 120 patients presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 16 Mar 2011 New trial record
- 19 Feb 2011 Results presented at the 2011 Genitourinary Cancers Symposium.